Skip to content
2000
Volume 21, Issue 11
  • ISSN: 1570-1808
  • E-ISSN: 1875-628X

Abstract

Among N-containing heterocycles, pyridine occupies a prominent position due to its presence in nature. Many enzymes in living systems, which are involved in redox reactions, contain pyridine moiety. In addition, its importance in medicinal chemistry and its presence in drugs are well documented. Several pyridine containing compounds are well-known as tubulin polymerization inhibitors and are found to bind with androgen receptors, kinases, carbonic anhydrase and topoisomerase. In recent years, researching have been modifying pyridine containing entities to treat cancer. This review sheds light on recent developments in anticancer studies of pyridine ring-fused heterocyclic compounds.

Loading

Article metrics loading...

/content/journals/lddd/10.2174/1570180820666230516111340
2024-09-01
2025-01-28
Loading full text...

Full text loading...

/content/journals/lddd/10.2174/1570180820666230516111340
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test